Pages that link to "Q24625180"
Jump to navigation
Jump to search
The following pages link to Mutant proteins as cancer-specific biomarkers (Q24625180):
Displaying 50 items.
- Recent progress in pancreatic cancer (Q24626346) (← links)
- The Size of the Human Proteome: The Width and Depth (Q26746173) (← links)
- Surgical and molecular pathology of pancreatic neoplasms (Q26748615) (← links)
- Yessotoxin, a Promising Therapeutic Tool (Q26772932) (← links)
- Applications of targeted proteomics in systems biology and translational medicine (Q26852271) (← links)
- Early diagnosis of pancreatic cancer: challenges and new developments (Q27014027) (← links)
- Impact of allele-specific peptides in proteome quantification (Q27016149) (← links)
- Global Cell Proteome Profiling, Phospho-signaling and Quantitative Proteomics for Identification of New Biomarkers in Acute Myeloid Leukemia Patients (Q33555287) (← links)
- TSNAD: an integrated software for cancer somatic mutation and tumour-specific neoantigen detection (Q33630241) (← links)
- Serum Levels of Glycoproteins are Elevated in Patients with Ovarian Cancer (Q33774597) (← links)
- Proteogenomic convergence for understanding cancer pathways and networks (Q33792433) (← links)
- Exosomes in bodily fluids are a highly stable resource of disease biomarkers (Q33885679) (← links)
- Identification of trunk mutations in gastric carcinoma: a case study (Q33921459) (← links)
- Ras in Cancer and Developmental Diseases (Q34202697) (← links)
- Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions (Q34279143) (← links)
- Genetic evolution of pancreatic cancer: lessons learnt from the pancreatic cancer genome sequencing project (Q34630956) (← links)
- Quantitative analysis of single amino acid variant peptides associated with pancreatic cancer in serum by an isobaric labeling quantitative method. (Q34669441) (← links)
- Identification of a novel proteoform of prostate specific antigen (SNP-L132I) in clinical samples by multiple reaction monitoring (Q34810177) (← links)
- Emerging tactical strategies for fighting the war on cancer based on the genetic landscape (Q35008971) (← links)
- Serial analysis of 38 proteins during the progression of human breast tumor in mice using an antibody colocalization microarray. (Q35325472) (← links)
- The use of protein-based biomarkers for the diagnosis of cystic tumors of the pancreas (Q35450240) (← links)
- Evaluating kinase ATP uptake and tyrosine phosphorylation using multiplexed quantification of chemically labeled and post-translationally modified peptides. (Q35579916) (← links)
- Proteomics in cancer biomarkers discovery: challenges and applications. (Q35592114) (← links)
- Using quantitative proteomic analysis to understand genotype specific intrinsic drug resistance in melanoma (Q35640196) (← links)
- Different toxic effects of YTX in tumor K-562 and lymphoblastoid cell lines (Q35749454) (← links)
- Absolute Quantification of Endogenous Ras Isoform Abundance (Q35839061) (← links)
- A proteomic approach to obesity and type 2 diabetes (Q35879468) (← links)
- Evaluation of Direct Infusion-Multiple Reaction Monitoring Mass Spectrometry for Quantification of Heat Shock Proteins (Q35903689) (← links)
- Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics (Q36031629) (← links)
- Advances in Proteomic Technologies and Its Contribution to the Field of Cancer (Q36112651) (← links)
- Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum (Q36280125) (← links)
- Detection of a rare BCR-ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS) (Q36342992) (← links)
- The clinical impact of recent advances in LC-MS for cancer biomarker discovery and verification (Q36771005) (← links)
- Protein isoform-specific validation defines multiple chloride intracellular channel and tropomyosin isoforms as serological biomarkers of ovarian cancer (Q37187957) (← links)
- Proteogenomics: Integrating Next-Generation Sequencing and Mass Spectrometry to Characterize Human Proteomic Variation (Q37190570) (← links)
- Mass spectrometric protein maps for biomarker discovery and clinical research (Q37324690) (← links)
- A proteogenomic approach for protein-level evidence of genomic variants in cancer cells (Q37335640) (← links)
- Long-gradient separations coupled with selected reaction monitoring for highly sensitive, large scale targeted protein quantification in a single analysis. (Q37341145) (← links)
- Comparison of protein immunoprecipitation-multiple reaction monitoring with ELISA for assay of biomarker candidates in plasma. (Q37394942) (← links)
- Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry (Q37618631) (← links)
- Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach (Q37623655) (← links)
- Large-scale mass spectrometric detection of variant peptides resulting from nonsynonymous nucleotide differences (Q37626189) (← links)
- The Application of Multiplexed Assay Systems for Molecular Diagnostics (Q37952394) (← links)
- Towards clinical applications of selected reaction monitoring for plasma protein biomarker studies (Q37972865) (← links)
- Mass spectrometry‐based targeted quantitative proteomics: Achieving sensitive and reproducible detection of proteins (Q38009277) (← links)
- The current status of clinical proteomics and the use of MRM and MRM(3) for biomarker validation (Q38012171) (← links)
- Analysing signalling networks by mass spectrometry (Q38028384) (← links)
- Quantitative mass spectrometry for colorectal cancer proteomics (Q38048726) (← links)
- Affinity-based microarrays for proteomic analysis of cancer tissues. (Q38076080) (← links)
- Molecular diagnostics of pancreatic cysts (Q38143609) (← links)